Ligands acting at the benzodiazepine (BZ) site of ␥-aminobutyric acid type A (GABAA) receptors currently are the most widely used hypnotics. BZs such as diazepam (Dz) potentiate GABAA receptor activation. To determine the GABAA receptor subtypes that mediate the hypnotic action of Dz wild-type mice and mice that harbor Dz-insensitive ␣1 GABAA receptors [␣1 (H101R) mice] were compared. Sleep latency and the amount of sleep after Dz treatment were not affected by the point mutation. An initial reduction of rapid eye movement (REM) sleep also occurred equally in both genotypes. Furthermore, the Dz-induced changes in the sleep and waking electroencephalogram (EEG) spectra, the increase in power density above 21 Hz in non-REM sleep and waking, and the suppression of slow-wave activity (SWA; EEG power in the 0.75-to 4.0-Hz band) in non-REM sleep were present in both genotypes. Surprisingly, these effects were even more pronounced in ␣1(H101R) mice and sleep continuity was enhanced by Dz only in the mutants. Interestingly, Dz did not affect the initial surge of SWA at the transitions to sleep, indicating that the SWA-generating mechanisms are not impaired by the BZ. We conclude that the REM sleep inhibiting action of Dz and its effect on the EEG spectra in sleep and waking are mediated by GABAA receptors other than ␣1, i.e., ␣2, ␣3, or ␣5 GABAA receptors. Because ␣1 GABAA receptors mediate the sedative action of Dz, our results provide evidence that the hypnotic effect of Dz and its EEG ''fingerprint'' can be dissociated from its sedative action.F ast synaptic inhibition in the mammalian central nervous system is largely mediated by activation of ␥-aminobutyric acid type A (GABA A ) receptors. GABA A receptors are heteromeric membrane proteins that operate as GABA-gated ion channels. Most GABA A receptors are composed of ␣, , and ␥ 2 subunits with a pentameric stoichiometry (1). GABA A receptor function can be enhanced by allosteric modulators, e.g., benzodiazepines (BZ), barbiturates, and neurosteroids. This enhancement of neuronal inhibition by GABA is one of the most powerful therapeutic strategies for treatment of central nervous system diseases such as sleep disturbances, anxiety disorders, muscle spasms, and seizure disorders (2). Classical BZ like diazepam (Dz) bind to GABA A receptors that contain the ␣ subunits ␣1, ␣2, ␣3 or ␣5, hereafter called ␣1, ␣2, ␣3, or ␣5 GABA A receptors, respectively (3). GABA A receptors containing the ␣4 or ␣6 subunits are insensitive to Dz. The ␣ subunits show distinct patterns of distribution in the brain (4).The ␣1 GABA A receptors represent Ϸ60% of all Dz-sensitive GABA A receptors in the brain and are found mainly in the cerebral and cerebellar cortex, thalamus, and pallidum (4). To assess the functions of this most prevalent receptor subtype in the pharmacological spectrum of Dz, a point-mutated knock-in mouse line, [␣1(H101R)], in which the ␣1 GABA A receptors are insensitive to Dz, has been developed (5, 6). These mice represent a useful tool to distinguish between Dz acti...